Does physical inactivity cause chronic obstructive pulmonary disease?

Clinical Science

Volumn 118, Issue 9, 2010, Pages 565-572

  Hopkinson, Nicholas S ^a   Polkey, Michael I ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease (COPD); Co morbidity; Exercise; Lung function; Oxidative stress; Smoking

Indexed keywords

CYTOKINE; HISTONE DEACETYLASE; PROSTACYCLIN; THROMBOXANE A2;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL EFFECTIVENESS; COMORBIDITY; EXERCISE; HUMAN; IMMOBILIZATION; LIFESTYLE MODIFICATION; LUNG FUNCTION TEST; MOLECULAR MECHANICS; OXIDATIVE STRESS; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PULMONARY REHABILITATION; PULMONARY VASCULAR DISEASE; RESPIRATORY FAILURE; RISK REDUCTION; SPIROMETRY; UPPER RESPIRATORY TRACT INFECTION;

ADULT; AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MOTOR ACTIVITY; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 76849107903     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090458     Document Type: Article

References (95)

1. Pauwels, R. A., Buist, A. S., Calverley, P. M., Jenkins, C. R. and Hurd, S. S. (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am. J. Respir. Crit. Care Med. 163, 1256-1276.
2. Buist, A. S., McBurnie, M. A. Vollmer, W.M. Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B. et al. (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370, 741-750
3. Murray, C. J. and Lopez, A. D. (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349, 1498-1504
4. Barnes, P. J. and Celli, B. R. (2009) Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 33, 1165-1185
5. Decramer, M., Rennard, S., Troosters, T., Mapel, D.W., Giardino, N., Mannino, D., Wouters, E., Sethi, S. and Cooper, C. B. (2008) COPD as a lung disease with systemic consequences: clinical impact, mechanisms, and potential for early intervention. COPD 5, 235-256
6. Chinn, S., Jarvis, D., Melotti, R., Luczynska, C., Ackermann-Liebrich, U., Anto, J. M., Cerveri, I., de Marco, R., Gislason, T., Heinrich, J. et al. (2005) Smoking cessation, lung function, and weight gain: a follow-up study. Lancet 365, 1629-1635
7. Kohansal, R., Martinez-Camblor, P., Agusti, A., Buist, A. S., Mannino, J. B. and Soriano, D. M. (2009) The natural history of chronic airflow obstruction revisited: an analysis of the Framingham Offspring Cohort. Am. J. Respir. Crit. Care Med. 180, 3-10
8. Camilli, A. E., Burrows, B., Knudson, R. J., Lyle, S. K. and Lebowitz, M. D. (1987) Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am. Rev. Respir. Dis. 135, 794-799
9. Anthonisen, N. R., Connett, J. E., Kiley, J. P., Altose, M. D., Bailey, W. C., Buist, A. S., Conway, Jr, W. A., Enright, P. L., Kanner, R. E. and O'Hara, P. (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study. JAMA, J. Am. Med. Assoc. 272, 1497-1505
10. Anthonisen, N. R. (2005) The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann. Int. Med. 142, 233-239
11. Bednarek, M., Gorecka, D., Wielgomas, J., Czajkowska-Malinowska, M., Regula, J., Mieszko-Filipczyk, G., Jasionowicz, M., Bijata-Bronisz, R., Lempicka-Jastrzebska, M. and Czajkowski, M. (2006) Smokers with airway obstruction are more likely to quit smoking. Thorax 61, 869-873
12. Gorecka, D., Bednarek, M., Nowinski, A., Puscinska, E., Goljan-Geremek, A. and Zielinski, J. (2003) Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest 123, 1916-1923
13. Lokke, A., Lange, P., Scharling, H., Fabricius, P. and Vestbo, J. (2006) Developing COPD: a 25 year follow up study of the general population. Thorax 61, 935-939
14. Miravitlles, M., Anzueto, A., Legnani, D., Forstmeier, L. and Fargel, M. (2007) Patient's perception of exacerbations of COPD: the PERCEIVE study. Respir. Med. 101, 453-460
15. Watz, H., Waschki, B., Meyer, T. and Magnussen, H. (2009) Physical activity in patients with COPD. Eur. Respir. J. 33, 262-272
16. Serres, I., Gautier, V., Varray, A. and Prefaut, C. (1998) Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 113, 900-905
17. Steele, B. G., Holt, L., Belza, B., Ferris, S., Lakshminaryan, S. and Buchner, D. (2000) Quantitating physical activity in COPD using a triaxial accelerometer. Chest 117, 1359-1367
18. Pitta, F., Troosters, T., Spruit, M. A., Probst, V. S., Decramer, M. and Gosselink, R. (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 171, 972-977
19. Garcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P. and Anto, J. M. (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61, 772-778
20. Pitta, F., Troosters, T., Probst, V. S., Spruit, M. A., Decramer, M. and Gosselink, R. (2006) Physical activity and hospitalization for exacerbation of COPD. Chest 129, 536-544
21. Spencer, S. and Jones, P.W. (2003) Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 58, 589-593
22. Donaldson, G. C., Wilkinson, T. M., Hurst, J. R., Perera, W. R. and Wedzicha, J. A. (2005) Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 171, 446-452
23. Kim, S., Emerman, C. L., Cydulka, R. K., Rowe, B. H., Clark, S. and Camargo, C. A. (2004) Prospective multicenter study of relapse following emergency department treatment of COPD exacerbation. Chest 125, 473-481
24. Garcia-Aymerich, J., Farrero, E., Felez, M. A., Izquierdo, J., Marrades, R. M. and Anto, J. M. (2003) Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58, 100-105
25. Hopkinson, N. S., Nickol, A. H., Payne, J., Hawe, E., Man, W. D., Moxham, J., Montgomery, H. and Polkey, M. I. (2004) Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170, 395-399
26. Gea, J., Orozco-Levi, M., Barreiro, E., Ferrer, A. and Broquetas, J. (2001) Structural and functional changes in the skeletal muscles of COPD patients: the "compartments" theory. Monaldi Arch. Chest Dis. 56, 214-224
27. Man, W. D., Soliman, M. G., Nikoletou, D., Harris, M. L., Rafferty, G. F., Mustfa, N., Polkey, M. I. and Moxham, J. (2003) Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax 58, 665-669
28. Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A. and Wouters, E. F. (2005) Body composition and mortality in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 82, 53-59
29. Marquis, K., Debigare, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G. and Maltais, F. (2002) Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 166, 809-813
30. Mostert, R., Goris, A., Weling-Scheepers, C., Wouters, E. F. and Schols, A. M. (2000) Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir. Med. 94, 859-867
31. Hamilton, A., Killian, K., Summers, E. and Jones, N. (1995) Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am. J. Respir. Crit. Care Med. 152, 2021-2031
32. Bernard, S., LeBlanc, P., Whittom, F., Carrier, G., Jobin, J., Belleau, R. and Maltais, F. (1998) Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 158, 629-634
33. Gosselink, R., Troosters, T. and Decramer, M. (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am. J. Respir. Crit. Care Med. 153, 976-980
34. Swallow, E. B., Reyes, D., Hopkinson, N. S., Man, W. D., Porcher, R., Cetti, E. J., Moore, A. J., Moxham, J. and Polkey,M. I. (2007) Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62, 115-120
35. Spruit, M. A., Gosselink, R. T., Kasran, A., Gayan-Ramirez, G., Bogaerts, P., Bouillon, R. and Decramer, M. (2003) Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 58, 752-756
36. Crul, T., Spruit, M. A., Gayan-Ramirez, G., Quarck, R., Gosselink, R., Troosters, T., Pitta, F. and Decramer, M. (2007) Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur. J. Clin. Invest. 37, 897-904
37. Martinez-Llorens, J. M., Orozco-Levi, M., Masdeu, M. J., Coronell, C., Ramirez-Sarmiento, A., Sanjuas, C., Broquetas, J. M. and Gea, J. (2004) Global muscle dysfunction and exacerbation of COPD: a cohort study. Med. Clin. 122, 521-527
38. Seymour, J. M., Spruit, M. A., Hopkinson, N. S., Sathyapala, S. A., Man, W. D. C., Jackson, A., Gosker, H. R., Schols, A. M. W. J., Moxham, J., Polkey, M. I. and Wouters, E. F. M. (2009) The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur. Respir. J. doi: 09031936.00104909
39. Manson, J. E., Greenland, P., LaCroix, A. Z., Stefanick, M. L., Mouton, C. P., Oberman, A., Perri, M. G., Sheps, D. S., Pettinger, M. B. and Siscovick, D. S. (2002) Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N. Engl. J. Med. 347, 716-725
40. Jonker, J. T., De Laet, C., Franco, O. H., Peeters, A., Mackenbach, J. and Nusselder, W. J. (2006) Physical activity and life expectancy with and without diabetes: life table analysis of the Framingham Heart Study. Diabetes Care 29, 38-43
41. Mokdad, A. H., Marks, J. S., Stroup, D. F. and Gerberding, J. L. (2004) Actual causes of death in the United States, 2000. JAMA, J. Am. Med. Assoc. 291, 1238-1245
42. Byberg, L., Melhus, H., Gedeborg, R., Sundstrom, J., Ahlbom, A., Zethelius, B., Berglund, L. G., Wolk, A. and Michaelsson, K. (2009) Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ 338, b688
43. Griffiths, T. L., Burr, M. L., Campbell, I. A., Lewis-Jenkins, V., Mullins, J., Shiels, K., Turner-Lawlor, P. J., Payne, N., Newcombe, R. G., Ionescu, A. A. et al. (2000) Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 355, 362-368
44. Griffiths, T. L., Phillips, C. J., Davies, S., Burr, M. L. and Campbell, I. A. (2001) Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 56, 779-784
45. Golmohammadi, K., Jacobs, P. and Sin, 6D. D. (2004) Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease. Lung 182, 187-196
46. California Pulmonary Rehabilitation, Collaborative Group (2004) Effects of pulmonary rehabilitation on dyspnea, quality of life, and healthcare costs in California. J. Cardiopulm. Rehabil. 24, 52-62
47. Cote, C. G. and Celli, B. R. (2005) Pulmonary rehabilitation and the BODE index in COPD. Eur. Respir. J. 26, 630-636
48. Man, W. D., Polkey, M. I., Donaldson, N., Gray, B. J. and Moxham, J. (2004) Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 329, 1209
49. Garcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P. and Anto, J. M. (2007) Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am. J. Respir. Crit. Care Med.. 175, 458-463
50. Garcia-Aymerich, J., Lange, P., Serra, I., Schnohr, P. and Antó, J. M. (2008) Time-dependent confounding in the study of the effects of regular physical activity in chronic obstructive pulmonary disease: an application of the Marginal Structural Model. Ann. Epidemiol. 18, 775-783
51. Jakes, R. W., Day, N. E., Patel, B., Khaw, K. T., Oakes, S., Luben, R., Welch, A., Bingham, S. and Wareham, N. J. (2002) Physical inactivity is associated with lower forced expiratory volume in 1 second: European Prospective Investigation into Cancer-Norfolk Prospective Population Study. Am. J. Epidemiol. 156, 139-147
52. Pelkonen, M., Notkola, I.-L., Lakka, T., Tukiainen, H. O., Kivinen, P. and Nissinen, A. (2003) Delaying decline in pulmonary function with physical activity: a 25-year follow-up. Am. J. Respir. Crit. Care Med. 168, 494-499
53. Twisk, J., Staal, B., Brinkman, M., Kemper, H. and van Mechelen, W. (1998) Tracking of lung function parameters and the longitudinal relationship with lifestyle. Eur. Respir. J. 12, 627-634
54. Canoy, D., Pekkanen, J., Elliott, P., Pouta, A., Laitinen, J., Hartikainen, A.-L., Zitting, P., Patel, S., Little, M. P. and Jarvelin, M.-R. (2007) Early growth and adult respiratory function in men and women followed from the fetal period to adulthood. Thorax 62, 396-402
55. Cheng, Y. J., Macera, C. A., Addy, C. L., Sy, F. S., Wieland, D. and Blair, S. N. (2003) Effects of physical activity on exercise tests and respiratory function. Br. J. Sports Med. 37, 521-528
56. Sandvik, L., Erikssen, G. and Thaulow, E. (1995) Long term effects of smoking on physical fitness and lung function: a longitudinal study of 1393 middle aged Norwegian men for seven years. Br. Med. J. 311, 715-718
57. Church, D. F. and Pryor, W. A. (1985) Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 64, 111-126
58. Bloomer, R., (2007) Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: impact of dietary intake. Nutr. J. 6, 39
59. Dietrich, M., Block, G., Norkus, E. P., Hudes, M., Traber, M. G., Cross, C. E. and Packer, L. (2003) Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase γ-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am. J. Clin. Nutr. 77, 160-66
60. Van der Vaart, H., Postma, D. S., Timens, W. and Ten Haccken, N. H. T. (2004) Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59, 713-721
61. MacNee, W. (2000) Oxidants/antioxidants and COPD. Chest 117, 303S-317S
62. Barreiro, E., Schols, A. M.W. J., Polkey, M. I., Galdiz, J. B., Gosker, H. R., Swallow, E. B., Coronell, C. and Gea, J. (2008) Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63, 100-107
63. Stevenson, C. S., Koch, L. G. and Britton, S. L. (2006) Aerobic capacity, oxidant stress, and chronic obstructive pulmonary disease: a new take on an old hypothesis. Pharmacol. Ther. 110, 71-82
64. Powers, S. K. (2005) Mechanisms of disuse muscle atrophy: role of oxidative stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R337-R344
65. Siu, P. M., Pistilli, E. E. and Alway, S. E. (2008) Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading. J. Appl. Physiol. 105, 1695-1705
66. Montes de Oca, M., Loeb, E., Torres, S. H., De Sanctis, J., Hernandez, N. and Talamo, C. (2008) Peripheral muscle alterations in non-COPD smokers. Chest 133, 13-18
67. Swallow, E. B., Barreiro, E., Gosker, H., Sathyapala, S. A., Sanchez, F., Hopkinson, N. S., Moxham, J., Schols, A., Gea, J. and Polkey, M. I. (2009) Quadriceps muscle strength in scoliosis. Eur. Respir. J. 34, 1429-1435
68. Ji, L. (2002) Exercise-induced modulation of antioxidant defense. Ann. N.Y. Acad. Sci. 959, 82-92
69. Fatouros, I. G., Jamurtas, A. Z., Villiotou, V., Pouliopoulou, S., Fotinakis, P., Taxildaris, K. and Deliconstantinos, G. (2004) Oxidative stress responses in older men during endurance training and detraining. Med. Sci. Sports Exercise 36, 2065-2072
70. Elosua, R., Molina, L., Fito, M., Arquer, A., Sanchez-Quesada, J. L., Covas, M. I., Ordoñez-Llanos, J. and Marrugat, J. (2003) Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis 167, 327-334
71. Bloomer, R., Solis, A., Fisher-Wellman, K. and Smith,W. (2008) Postprandial oxidative stress is exacerbated in cigarette smokers. Br. J. Nutr. 99, 1055-1060
72. Bloomer, R. J. and Fisher-Wellman, K. (2009) The role of exercise in minimizing postprandial oxidative stress in cigarette smokers. Nicotine Tob. Res. 11, 3-11
73. Mercken, E. M., Hageman, G. J., Schols, A. M. W. J., Akkermans, M. A., Bast, A. and Wouters, E. F. M. (2005) Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 172, 994-1001
74. Walter, R. E.,Wilk, J. B., Larson, M. G., Vasan, R. S., Keaney, Jr, J. F., Lipinska, I., O'Connor, G. T. and Benjamin, E. J. (2008) Systemic inflammation and COPD: The Framingham Heart Study. Chest 133, 19-25
75. Geffken, D. F., Cushman, M., Burke, G. L., Polak, J. F., Sakkinen, P. A. and Tracy, R. P. (2001) Association between physical activity and markers of inflammation in a healthy elderly population. Am. J. Epidemiol. 153, 242-250
76. Steensberg, A., Fischer, C. P., Keller, C., Moller, K. and Pedersen, B. K. (2003) IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am. J. Physiol. Endocrinol. Metab. 285, E433-E437
77. Petersen, A. M.W. and Pedersen, B. K. (2005) The anti-inflammatory effect of exercise. J. Appl. Physiol. 98, 1154-1162
78. Pedersen, B. K., Steensberg, A., Fischer, C., Keller, C., Keller, P., Plomgaard, P., Febbraio, M. and Saltin, B. (2003) Searching for the exercise factor: is IL-6 a candidate? J. Muscle Res. Cell Motil. 24, 113-119
79. Keller, C., Steensberg, A., Pilegaard, H., Osada, T., Saltin, B., Pedersen, B. K. and Neufer, P. D. (2001) Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J. 15, 2748-2750
80. Starkie, R., Ostrowski, S. R., Jauffred, S., Febbraio, M. and Pedersen, B. K. (2003) Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α aproduction in humans. FASEB J. 17, 884-886
81. Bruce, C. R. and Dyck, D. J. (2004) Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-α. Am. J. Physiol. Endocrinol. Metab. 287, E616-E621
82. Path, G., Bornstein, S. R., Gurniak, M., Chrousos, G. P., Scherbaum, W. A. and Hauner, H. (2001) Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. J. Clin. Endocrinol. Metab. 86, 2281-2288
83. Petersen, E.W., Carey, A. L., Sacchetti, M., Steinberg, G. R., Macaulay, S. L., Febbraio, M. A. and Pedersen, B. K. (2005) Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am. J. Physiol. Endocrinol. Metab. 288, E155-E162
84. Moreira, A., Delgado, L., Moreira, P. and Haahtela, T. (2009) Does exercise increase the risk of upper respiratory tract infections? Br. Med. Bull. 90, 111-131
85. Matthews, C. E., Ockene, I. S., Freedson, P. S., Rosal, M. C., Merriam, P. A. and Hebert, J. R. (2002) Moderate to vigorous physical activity and risk of upper-respiratory tract infection. Med. Sci. Sports Exercise 34, 1242-1248
86. Garcia-Aymerich, J., Serra, I., Gómez, F. P., Farrero, E., Balcells, E., Rodríguez, D. A., de Batlle, J., Gimeno, E., Donaire-Gonzalez, D., Orozco-Levi, M. et al. (2009) Physical activity and clinical and functional status in COPD. Chest 136, 62-70
87. Wilkinson, T.M.A., Patel, I.S., Wilks, M., Donaldson, G.C. and Wedzicha, J. A. (2003) Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 167, 1090-1095
88. Wilkinson, T. M. A., Donaldson, G. C., Johnston, S. L., Openshaw, P. J. M. and Wedzicha, J. A. (2006) Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173, 871-876
89. Rauramaa, R., Salonen, J. T., Kukkonen-Harjula, K., Seppanen, K., Seppala, E., Vapaatalo, H. and Huttunen, J. K. (1984) Effects of mild physical exercise on serum lipoproteins and metabolites of arachidonic acid: a controlled randomised trial in middle aged men. Br. Med. J. 288, 603-606
90. Christman, B. W., McPherson, C. D., Newman, J. H., King, G. A., Bernard, G. R., Groves, B. M. and Loyd, J. E. (1992) An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 327, 70-75
91. Tobias, M., Jackson, G., Yeh, L.-C. and Huang, K. (2007) Do healthy and unhealthy behaviours cluster in New Zealand? Aust. NZ J. Public Health 31, 155-163
92. Pearson, N., Atkin, A., Biddle, S., Gorely, T. and Edwardson, C. (2009) Patterns of adolescent physical activity and dietary behaviours. Int. J. Behav. Nutr. Phys. Act. 6, 45
93. Watz, H., Waschki, B., Boehme, C., Claussen, M., Meyer, T. and Magnussen, H. (2008) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am. J. Respir. Crit. Care Med. 177, 743-751
94. Ussher, M. H., Taylor, A. and Faulkner, G. (2008) Exercise interventions for smoking cessation. Cochrane Database Syst. Rev. CD002295, doi: 10.1002/14651858.CD002295.pub3
95. Hopkinson, N. S., Li, K. W., Kehoe, A., Humphries, S. E., Roughton, M., Moxham, J., Montgomery, H. and Polkey, M. I. (2008) Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 87, 385-390